Home » today » Health » Next Tuesday they will begin to vaccinate boys between 3 and 11 years old

Next Tuesday they will begin to vaccinate boys between 3 and 11 years old

On Tuesday, October 12, this new vaccination campaign will begin in this sector of the population, which according to official estimates in Santa Fe is around 450 thousand children. Already registered in Santa Fe Vacuna, about 100,000 are surveyed.

What this Monday was also defined at the provincial level is that it will start with the children who present risk factors or comorbidities with a descending shift criterion: first the 11-year-olds will be cited and then in a staggered way until reach 3 years.

“We participated in a new Cofesa meeting and we addressed the vaccination of this age group. On the weekend the doses will arrive, the total population of Santa Fe from 3 to 11 years old is 450 thousand, although now we will start with those with risk factors ”, confirmed yesterday the Minister of Health Santa Fe, Sonia Martorano, and stressed that the Sinopharm vaccine has “attenuated virus” technology and does not require special cold logistics.

“The platform of this vaccine is similar to that of the flu, it is a very safe vaccine, which we will begin to apply on Tuesday, October 12, advancing in descending order and prioritizing people with risk factors,” said the minister.

It should be remembered that the Argentine Society of Pediatrics (SAP), an entity led by Rosario Omar Tabacco, had requested that vaccination start with prioritized groups.

The request was made within hours of the authorization that Anmat made for the application of Sinopharm in the population aged 3 to 11 years.

The SAP had been in favor of vaccinating children through “safe vaccines as a tool to protect their own health” (this Chinese laboratory produced this vaccine with inactivated viruses), and in turn as an impetus to reduce circulation community of Covid among the population and a kind of passport to support school attendance.

In any case, while Cofesa resolved the kick for the vaccination of this population, the scientific and medical community was still debating “scientific evidence” that underpins the decision adopted by Minister Vizzotti

Last night, at a press conference Vizzotti warned that “cases in minors are increasing” and announced that there will be follow-up committees in the provinces to monitor their effectiveness. The country has 10 million doses of this vaccine of Chinese origin and there will be two million more before November.

“Argentina will end 2021 with its entire population over 3 years covered,” the minister had said.

Two million

In another order, Minister Martorano made a balance on the vaccination operation with two million Santa Fe with a complete scheme, (57 percent of the population); and with at least one dose it is around 70 percent.

“We are very little from completing the total doses and waiting for the arrival of more vaccines. We are doing very well with the deadlines, moving forward with this 12 to 17 year operation with the Pfizer vaccine. With the 17-year-old vaccinated, we started with the 16-year-old ”, he said, recalling that one must register in the vaccination registry and also be attentive to the call for second doses.

What are the prioritized groups

From the province they recalled what are the factors that define patients between 3 and 11 years old who will be summoned from next Tuesday to be vaccinated:

Type 1 or 2 diabetes (insulin-dependent and non-insulin-dependent). patients with obesity, cardiac and pulmonary pathologies. Chronic kidney disease (including patients on chronic dialysis).

People with cirrhosis, with HIV, on the waiting list for organ transplants and transplants. People with disabilities living in homes, with Down Syndrome.

Oncological and oncohematological patients, undergoing chemotherapy, and those who are suffering from active tuberculosis (new case or relapse, diagnosed in the last 12 months), and those who have intellectual disabilities, institutionalized, in homes or residences.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.